ebook Munafa Stock Market Course + Intraday & FNO calls  

       

IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising

IONS NEWS reasons for why stock price of Ionis Pharmaceuticals, Inc. is falling or rising

IONS Ionis Pharmaceuticals is falling or rising technical reasons

Technical analysis forecast for Ionis Pharmaceuticals Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Ionis Pharmaceuticals IONS at this time. Stock is falling and might fall more.

It appears as if Ionis Pharmaceuticals IONS gave a large move recently.

Stock of Ionis Pharmaceuticals (IONS) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Ionis Pharmaceuticals is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 43.3 as stoploss in an intra day buy trade for a target of 49.66. However, stock will show a bearish move below 43.3.

IONS Ionis Pharmaceuticals is falling or rising NEWS fundamental reasons

Gold rises ?607 as rate-hold expectations strengthen; silver jumps ?2,828 In the global market, gold futures on Comex were trading near ,200 per ounce, while silver was trading near .40 per ounce - NEWS as on 2026-10-01 business-standard.com

PB Fintech sinks 43% in four sessions as IRDAI proposals spark concerns PB Fintech slumped 6.11% to Rs 1,081 on Tuesday, extending its decline to 42.69% in four trading sessions. - NEWS as on 2026-09-29 business-standard.com

Irdai commission caps likely to hit jobs, weaken reach, cautions IBAI Brokers' body says proposed commission caps and lower expense limits could lead to job losses, weaken independent distribution and hurt insurance access in smaller towns. - NEWS as on 2026-09-29 business-standard.com

Visa-owned Pismo live with eight institutions in India, plans expansion The core banking and card processing platform is exploring credit line on UPI and other use cases as India becomes one of its priority markets for FY27 - NEWS as on 2026-09-28 business-standard.com

AZZ Raises Outlook as Infrastructure, Data Centers and Acquisitions Drive Growth These 2 Must-Watch Firms Could Get a Boost From Earnings ReportsAZZ (NYSE:AZZ) outlined its growth strategy, updated financial outlook and acquisition priorities during a Sidoti investor presentation, highlighting demand from infrastructure, electrificatio - NEWS as on 2026-09-27 nasdaq.com

One 97 Communications hikes stake in its subsidiary - Little Internet Also invests Rs 100 cr in its wholly owned subsidiary- Paytm Money - NEWS as on 2026-09-25 business-standard.com

Tata Sons defends Chandra's reappointment, sends 3 legal opinions to Trusts Tata Trusts studying the response before any legal recourse - NEWS as on 2026-09-24 business-standard.com

Sebi approves reforms to PMS regulations, settlement proceedings The regulator has also approved allowing foreign portfolio investors to participate in non-agricultural commodity derivatives, along with a common advertisement code - NEWS as on 2026-09-24 business-standard.com

Instamart plans to expand battery-swapping stations network to boost EVs Quick commerce platform Instamart on Wednesday announced its plans to strengthen its battery-swapping stations network by installing facilities closer to its micro-fulfilment centres or dark stations to boost EV adoption in last-mile delivery. The company - NEWS as on 2026-09-23 business-standard.com

RNIT AI Solutions secures engagement with APSSDC For deployment of AI-based Multilingual Interview Platform - NEWS as on 2026-09-22 business-standard.com

RBI issues Directions on Minimum Capital Requirements for Market Risk under Basel III for Commercial Banks Accordingly, the Reserve Bank of India has today issued the Reserve Bank of India (Commercial Banks - Minimum Capital Requirements for Market Risk) Directions, 2026. The Directions aim to align the market risk guidelines with the revised Basel III framewor - NEWS as on 2026-09-21 business-standard.com

ASML begins India operations, plans to hire young engineering graduates Semiconductor equipment maker ASML has started operations in India and plans to hire 20-30 young engineering graduates initially to meet its requirement, a senior official of the company said. Speaking on the sidelines of SEMICON India 2026, ASML Executive - NEWS as on 2026-09-20 business-standard.com

Motorola Solutions Eyes Defense, Drone Security Growth as Silvus Scales Motorola's .5B Bet to Own the SkiesMotorola Solutions (NYSE:MSI) is focused on executing across its mission-critical networks, command center software and video security businesses while scaling its recently acquired Silvus Technologies and D-Fend Soluti - NEWS as on 2026-09-19 nasdaq.com

Lemonade Targets First EBITDA-Positive Quarter as CFO Tim Bixby Transitions to Board 3 Stocks That Prove the AI Trade Isn't Over, It MovedLemonade (NYSE:LMND) Chief Financial Officer Tim Bixby said the digital insurer expects to reach a significant profitability milestone in the fourth quarter, while continuing to prioritize growth, produc - NEWS as on 2026-09-18 nasdaq.com

Margin trading book hits record ?1.49 trn, cushions brokers amid slump MTF books at Angel One and Groww have grown strongly, providing brokerages an offset as overall trading volumes remain below the highs recorded in the June quarter - NEWS as on 2026-09-18 business-standard.com

More announcements and NEWS

IONS Ionis Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Ionis Pharmaceuticals, Inc.

  • 5Day Average: 44.71
  • 12Day Average: 46.45
  • 20Day Average: 51.18
  • 50Day Average: 54.74
  • 100Day Average: 63.96
  • 150Day Average: 67.67
  • 200Day Average: 71.03

IONS Indicators & signals

Indicator MACD (12,26,9)

47.18, 51.09, -3.42
Indicator MACD is in negative zone

Indicator ADX (14)

42.62, 14.96, 37.18
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of IONS Ionis Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
28 Mon Sep 2026 45.57 44.06 to 46.95 2.4% 0.7 times
25 Fri Sep 2026 44.50 43.62 to 45.28 1.6% 1.17 times
24 Thu Sep 2026 43.80 43.25 to 44.60 -0.3% 0.48 times
23 Wed Sep 2026 43.93 43.01 to 46.41 -3.98% 0.66 times
22 Tue Sep 2026 45.75 44.44 to 46.13 1.89% 0.8 times
21 Mon Sep 2026 44.90 44.20 to 45.25 1.04% 0.85 times
18 Fri Sep 2026 44.44 44.27 to 46.75 -4.94% 1.38 times
17 Thu Sep 2026 46.75 45.75 to 47.42 4.26% 0.77 times
16 Wed Sep 2026 44.84 44.66 to 47.59 -5.1% 1.49 times
15 Tue Sep 2026 47.25 46.72 to 51.37 -8.15% 1.28 times
14 Mon Sep 2026 51.44 51.31 to 55.50 -5.11% 1.12 times
11 Fri Sep 2026 54.21 54.16 to 56.16 -2.59% 0.41 times

Videos related to: IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising

 

Back to top